Marie Monika Anna Encrantz

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Alestra Ltd. manufactures & markets automobile parts and accessories for motor vehicles and their engines. The company was founded on November 19, 2002 and is located in London, UK.

Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden.

Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.

Koncentra Verkstads AB provides investment services to the manufacturing industry. It also offers management consulting services. The company was founded in 1999 and is headquartered in Askim, Sweden.

Harbour Solutions Group Ltd. provides investment advisory services. The British company was founded in 2007 by Martin Tonnby, Susan Jean Dunn, Charles Jeffery, and Gina Wasikowski. The CEO is Ellora MacPherson.

Allegro Investment Fund LP seeks investment opportunities in companies located in the US and Europe. The fund targets companies operating in the fields of infrastructure, power, defense, business services, health care. It provides financing for buyouts, recapitalizations, early and growth stage capital requirements with an investment size of $10-$50 million per transaction. It acts as lead investor and takes minority & majority positions. It also takes board seat requirements.

Oxymetal SAS specializes in metal cutting by means of laser, oxygen and plasma and metal forging. It offers thin metal sheet as well as aluminum welding cases, cabinets, racks and window casings. The company was founded by Bernard Surgot on January 18, 1984 and is headquartered in Bordeaux, France.

Nclear, Inc. manufactures commercial and service industry machinery. The company is based in Atlanta, GA. The company was founded in 2012 by Steven A. Odom. Mike Mies has been the CEO of the company since 2015.

Evolve Guest Controls LLC designs, installs and monitors solutions for connected spaces. The firm’s solutions include connected room, climate control, lighting control, shading and drapery solutions. The company was founded by Len Horowitz in 2007 and is headquartered in Chicago, IL.

Evolve Employee Incentive LLC operates as a development stage company. The company was founded in 2016 and is headquartered in Port Washington, NY.

Govx, Inc. develops GovX.com, a controlled-access e-commerce site. It serves the U.S. Armed Forces and government, including active, reserve, former and retired military personnel, and those in police, fire, FBI, DEA, Border Patrol, and related government agencies. The company was founded by Anthony Farwell on December 9, 2011 and is headquartered in San Diego, CA.

Main Street Broadband is an American company that operates a bistro and bakery in Waupun, Wisconsin. The private company's focus is on creating a cozy and inviting atmosphere for customers to enjoy a morning or afternoon meal with friends. The bistro offers a variety of dishes, including fresh baked goods. Mass. The company was founded by Paul J.

Normaction SA engages in providing telecommunications and computer security services to small and medium sized businesses. Its activities include telecommunication services and IT system security. The firm also offers landline telephone services like management of company subscriptions and communications, and assignment of special numbers; mobile telephone services; and, installation of PABX telephone centers. The company was founded in 1998 and is headquartered in Asnières-sur-Seine, France

Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.

Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway.

OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom.

Disruptive Pharma AB is a pharmaceutical company based in Uppsala, Sweden, with a passion for innovation in drug products. The Swedish company has perfected the groundbreaking mesoporous magnesium carbonate (mmc) drug delivery technology, which makes it easier to develop amorphous drug candidates. By combining the mmc formulation technology with drug compounds, they can enhance existing products or assist in formulating new therapies. Disruptive Pharma seeks commercial partnership or licensing to industry partners within the drug improvement business area. The company was founded in 2018 by Maria Strömme, and the CEO is Peter Åsberg.

Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021.

Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden.

NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden.

Haracon AB provides corporate consulting services.

Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden.

Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.

Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital.

TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden.